lomefloxacin has been researched along with Protein Aggregation, Pathological in 1 studies
lomefloxacin: structure given in first source
lomefloxacin : A fluoroquinolone antibiotic, used (generally as the hydrochloride salt) to treat bacterial infections including bronchitis and urinary tract infections. It is also used to prevent urinary tract infections prior to surgery.
Protein Aggregation, Pathological: A biochemical phenomenon in which misfolded proteins aggregate either intra- or extracellularly. Triggered by factors such as MUTATION; POST-TRANSLATIONAL MODIFICATIONS, and environmental stress, it is generally associated with ALZHEIMER DISEASE; PARKINSON DISEASE; HUNTINGTON DISEASE; and TYPE 2 DIABETES MELLITUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pérez-Areales, FJ | 1 |
| Di Pietro, O | 1 |
| Espargaró, A | 1 |
| Vallverdú-Queralt, A | 1 |
| Galdeano, C | 1 |
| Ragusa, IM | 1 |
| Viayna, E | 1 |
| Guillou, C | 1 |
| Clos, MV | 1 |
| Pérez, B | 1 |
| Sabaté, R | 1 |
| Lamuela-Raventós, RM | 1 |
| Luque, FJ | 1 |
| Muñoz-Torrero, D | 1 |
1 other study available for lomefloxacin and Protein Aggregation, Pathological
| Article | Year |
|---|---|
Shogaol-huprine hybrids: dual antioxidant and anticholinesterase agents with β-amyloid and tau anti-aggregating properties.
Topics: Acetylcholinesterase; Aminoquinolines; Amyloid beta-Peptides; Antioxidants; Catechols; Cholinesteras | 2014 |